Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy

Clinical trial NCT01656304 · COMPLETED

Trial details

NCT number: NCT01656304
Sponsor: Barbara Ann Karmanos Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Prostate Recurrent Prostate Cancer Stage I Prostate Cancer Stage IIA Prostate Cancer Stage IIB Prostate Cancer Stage III Prostate Cancer

Start date: 2007-05-01
Primary completion: 2012-01-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.